On August 20, 2012, Kenneth L. Sabot, a Class I director of RBC Life Sciences Inc. announced the company that he is resigning from the company's board of directors, effective immediately.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000067 USD | -33.00% | -.--% | -.--% |
2015 | RBC Life Sciences, Inc. Approves Resignation of Robert A. Kaiser as a Director | CI |
2015 | Tranche Update on RBC Life Sciences Inc.'s Equity Buyback Plan announced on August 28, 2013. | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.83K | |
-.--% | 843M | |
+0.79% | 675M | |
+27.62% | 465M | |
0.00% | 144M | |
+169.57% | 75.17M | |
-1.00% | 58.25M |
- Stock Market
- Equities
- RBCL Stock
- News RBC Life Sciences, Inc.
- RBC Life Sciences Inc. Announces Resignation of Kenneth L. Sabot as Class I Director